HempNewsBreaks – Neutra Corp. (NTRR) Executes LOI with Orgaceutical

Neutra Corp. (OTCQB: NTRR), an early-stage research and development company, this morning announced that it has executed a letter of intent (“LOI”) with Orgaceutical that could initiate the joint development of various additional hemp-based medicinal products. Per the agreement, Harrisburg, PA-based Orgaceutical will provide Neutra access to its formal research results to explore the use of cannabinoids as antioxidants and neuro-protectants. In addition, Neutra will obtain rights to a federally registered hemp trademark and a license for hemp cultivation issued by the Commonwealth of Pennsylvania’s Department of Agriculture. “This LOI will propel us into an excellent position for research and development of exciting new applications for hemp-based medicinal CBD products,” Neutra CEO Sydney Jim stated in the news release. “With the cultivation license, we’ll have a constant and consistent supply of quality hemp under a vertically integrated cultivation model. With the research license, we’ll be free to explore new uses for hemp and products derived from it. Finally, with the trademark, we’ll have a federally protected brand name to pair with our existing VIVIS product line.”

To view the full press release, visit http://cnw.fm/MBzV8

About Neutra Corp.

Neutra Corp. (NTRR) is an early-stage research and development company with a focus on bringing modern healthy living solutions to a multibillion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture—one where consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical submarkets is the thriving hemp-based CBD market, in which Neutra Corp. intends to participate. For more information, visit the company’s website at www.NeutraInc.com.

NOTE TO INVESTORS: The latest news and updates relating to GYSR are available in the company’s newsroom at http://cnw.fm/NTRR

About HempWire

HempWire (HW) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWire (HW) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.hempwire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.hempwire.com/Disclaimer

Do you have a questions or are you interested in working with HW? Ask our Editor

HempWire (HW)
Denver, Colorado
www.hempwire.com
303.498.7722 Office
Editor@HempWire.net